1.2.2.6 Opioid receptor antagonists
Expand All / Expand All (incl. cost)
Naldemedine is recommended as an option for treating opioid induced constipation in adults whose constipation has not adequately responded to laxatives. An inadequate response is defined as opioid-induced constipation symptoms of at least moderate severity in at least 1 of the 4 stool symptom domains (that is, incomplete bowel movement, hard stools, straining or false alarms) while taking at least 1 laxative class for at least 4 days during the prior 2 weeks.
For full details please see NICE TA 651 https://www.nice.org.uk/guidance/ta651
| Pack | Price |
|---|---|
| 28 tablet | £41.72 |
Documents
-
Primary Care
-
Secondary Care
-
Primary and Secondary Care
Naloxegol -EKPG Recommendation, Oct 2015
Uploaded By:
Renewal: 01/2020
Approved: 01/2019
Last Reviewed: 01/2019
Caution: This document is due for renewal and may be out of date
Document linked to:
| Drug | Section |
|---|---|
| Naloxegol |
1.2.2.6 Opioid receptor antagonists
|
| Pack | Price |
|---|---|
| 30 tablet | £55.20 |
| Pack | Price |
|---|---|
| 30 tablet | £55.20 |